Latest News

pier lambiase subcutaneous icds

EHRA 2021: Subcutaneous ICDs maintain cardioversion efficacy of 98% across five-year...

Subcutaneous implantable cardioverter defibrillator (S-ICD) devices have demonstrated a cardioversion efficacy rate of 98% over a period of at least five years in the...

Features

Looking ahead to AFIB2021

Far from being the first event in the electrophysiology calendar now to make the switch to a digital-only format, the 2021 edition of the...

Blood pressure bracelet “offers greater insight” into hypertension

Following the announcement of CE mark approval for the Aktiia cuffless blood pressure monitor bracelet, Gregoire Wuerzner (Lausanne University Hospital and University of Lausanne,...

Videos

Jens Erik Nielsen-Kudsk (Aarhus, Denmark) speaks to Cardiovascular News about a propensity score-matched study which examined left atrial appendage occlusion (LAAO) compared with novel oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with a high risk of stroke and...

Events

Athena Poppas

Eric Prystowsky

Eric N Prystowsky

Pedro Brugada